TrialInternational journal of chronic obstructive pulmonary disease

Real-life effectiveness of indacaterol-glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study.

Alan Kaplan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.